Walleye Trading
AGIO icon

Walleye Trading’s Agios Pharmaceuticals AGIO Stock Holding History

Walleye Trading’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-20,321
Closed -$453K – 4685
2023
Q4 		$453K Buy
+20,321
New +$455K ﹤0.01% 3166
2022
Q4 		– Sell
-3,678
Closed -$104K – 4918
2022
Q3 		$104K Buy
+3,678
New +$98.7K ﹤0.01% 4036
2022
Q2 		– Sell
-11,522
Closed -$335K – 5053
2022
Q1 		$335K Buy
11,522
+7,867
+215% +$240K ﹤0.01% 3343
2021
Q4 		$120K Buy
+3,655
New +$147K ﹤0.01% 4275
2021
Q1 		– Sell
-2,535
Closed -$110K – 4738
2020
Q4 		$110K Buy
+2,535
New +$100K ﹤0.01% 3886
2020
Q2 		– Sell
-4,995
Closed -$231K – 4196
2020
Q1 		$177K Buy
+4,995
New +$231K ﹤0.01% 2702
2019
Q4 		– Sell
-13,647
Closed -$516K – 4194
2019
Q3 		$442K Buy
+13,647
New +$565K ﹤0.01% 2261
2019
Q2 		– Sell
-1,172
Closed -$62.6K – 3976
2019
Q1 		$79K Sell
1,172
-23,330
-95% -$1.36M ﹤0.01% 3558
2018
Q4 		$1.13M Buy
24,502
+24,399
+23,688% +$1.51M 0.01% 1586
2018
Q3 		$8K Buy
+103
New +$8.29K ﹤0.01% 5023
2017
Q3 		– Sell
-100
Closed -$5K – 4040
2017
Q2 		$5K Buy
+100
New +$5.11K ﹤0.01% 4323

Other funds holding AGIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Walleye Trading's AGIO Position: Q1 2024 in Review

Walleye Trading sold out of Agios Pharmaceuticals (AGIO) in Q1 2024, closing a stake of 20,321 shares — an estimated $453K sold.

Walleye Trading first reported a position in AGIO in Q2 2017 and held it in 11 quarters. The position peaked at $1.13M in Q4 2018. 187 funds tracked by Wall St. Rank hold AGIO as of Q1 2024.

  • Walleye Trading reported no remaining Agios Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Walleye Trading sold 20,321 Agios Pharmaceuticals shares in Q1 2024, an estimated $453K.
  • Walleye Trading first reported a position in Agios Pharmaceuticals in Q2 2017 and held it in 11 quarters.
  • Walleye Trading's Agios Pharmaceuticals position peaked at $1.13M in Q4 2018.
  • 187 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2024.

Based on Walleye Trading's 13F filing for Q1 2024, filed 15 May 2024.